These families have been referred since then as familial colorectal cancer type X [19], and are characterized by MSS tumors, lower cancer risk and later onset of CRC (10 years after the median age of onset in LS), and a minor risk of extracolonic cancers compared to both MSH2 and MSH6 mutation carriers. This evidence concerns the gene MSH6 and colorectal carcinoma.